Literature DB >> 9464805

Anergic T cells effect linked suppression.

L Frasca1, P Carmichael, R Lechler, G Lombardi.   

Abstract

Although the phenomenon of T cell-mediated suppression is well established, particularly in experimental models of transplantation, the mechanisms involved in this form of immunoregulation remain controversial. We have recently demonstrated, using an in vitro system, that anergic T cells can act as suppressor cells by competing for the membrane of the antigen-presenting cell (APC) and for locally produced interleukin-2. In the experiments described here we have explored the ability of anergic T cells to effect linked suppression in antigen-specific and allospecific responses. We observed that anergic antigen-specific CD4+ T cells can inhibit T cells restricted by a different major histocompatibility complex (MHC) class II molecule provided that both restriction elements are expressed by the same APC. In addition, anergic allospecific clones could also effect linked suppression since they could regulate not only T cells specific for the same alloantigen but also responder T cells with direct allospecificity for a second allogeneic MHC molecule or with indirect, self MHC-restricted allospecificity for a processed MHC class I alloantigen. Furthermore, the regulatory effect of the anergic T cells was dependent on cell contact, was not dependent upon irradiation, and was maintained during in vitro culture. These data demonstrate that linked suppression can be effected by anergic T cells in vitro. In the clinical context this raises the possibility that induction of tolerance to a single alloantigen could serve to regulate the immune response to an allograft carrying several MHC and minor antigen differences.

Entities:  

Mesh:

Year:  1997        PMID: 9464805     DOI: 10.1002/eji.1830271216

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

Review 1.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  The contributions of T-cell anergy to peripheral T-cell tolerance.

Authors:  R Lechler; J G Chai; F Marelli-Berg; G Lombardi
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

3.  Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.

Authors:  Cecilia Oderup; Lukas Cederbom; Anna Makowska; Corrado M Cilio; Fredrik Ivars
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

Review 4.  Gene-modified dendritic cells for immunotherapy against cancer.

Authors:  Andreas Lundqvist; Pavel Pisa
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

5.  A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes.

Authors:  Brett Phillips; Karen Nylander; Jo Harnaha; Jennifer Machen; Robert Lakomy; Alexis Styche; Kimberly Gillis; Larry Brown; Debra Lafreniere; Michael Gallo; Janet Knox; Kenneth Hogeland; Massimo Trucco; Nick Giannoukakis
Journal:  Diabetes       Date:  2008-03-03       Impact factor: 9.461

Review 6.  The role of the FOXP3 transcription factor in the immune regulation of allergic asthma.

Authors:  Carsten B Schmidt-Weber; Kurt Blaser
Journal:  Curr Allergy Asthma Rep       Date:  2005-09       Impact factor: 4.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.